三力制药
(603439)
| 流通市值：54.28亿 | | | 总市值：54.28亿 |
| 流通股本：4.04亿 | | | 总股本：4.04亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 559,317,019.11 | 381,730,286.64 | 1,702,842,901.68 | 1,038,498,412.06 |
| 营业总成本 | 525,579,978.41 | 327,451,779.8 | 1,521,731,029.37 | 964,371,007.43 |
| 其他经营收益 | | | | |
| 营业利润 | 44,830,383.46 | 51,498,552.29 | 64,546,162.01 | 85,967,211.72 |
| 利润总额 | 43,728,938.43 | 51,426,005.24 | 67,765,454.3 | 92,653,437.43 |
| 净利润 | 37,790,787.92 | 45,137,915.51 | 48,153,602.74 | 83,677,317.23 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 37,790,787.92 | 45,137,915.51 | 48,153,602.74 | 83,677,317.23 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,265,117,951.98 | 1,498,801,210.55 | 1,529,587,271.89 | 1,409,230,079.09 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,301,112,544.89 | 1,311,922,175.46 | 1,318,335,247.15 | 1,438,938,454.05 |
| 资产总计 | 2,566,230,496.87 | 2,810,723,386.01 | 2,847,922,519.04 | 2,848,168,533.14 |
| 流动负债: | | | | |
| 流动负债合计 | 737,912,898.44 | 953,887,793.03 | 1,037,171,202.66 | 973,367,561.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 294,086,053.24 | 296,160,998.81 | 298,520,464.01 | 326,654,594.13 |
| 负债合计 | 1,031,998,951.68 | 1,250,048,791.84 | 1,335,691,666.67 | 1,300,022,155.19 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,467,305,951 | 1,493,212,758.28 | 1,445,596,999.4 | 1,480,680,738.64 |
| 股东权益合计 | 1,534,231,545.19 | 1,560,674,594.17 | 1,512,230,852.37 | 1,548,146,377.95 |
| 负债和股东权益合计 | 2,566,230,496.87 | 2,810,723,386.01 | 2,847,922,519.04 | 2,848,168,533.14 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 798,359,931.11 | 380,842,442.05 | 1,919,897,058.11 | 1,367,379,375.86 |
| 经营活动现金流出小计 | 687,385,080.46 | 367,248,656.85 | 1,755,320,033.74 | 1,317,315,740.69 |
| 经营活动产生的现金流量净额 | 110,974,850.65 | 13,593,785.2 | 164,577,024.37 | 50,063,635.17 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 540,099,233.14 | 88,400,517.87 | 104,312,530.32 | 62,253,447.96 |
| 投资活动现金流出小计 | 541,130,767.11 | 249,206,198 | 332,747,853.61 | 328,744,570 |
| 投资活动产生的现金流量净额 | -1,031,533.97 | -160,805,680.13 | -228,435,323.29 | -266,491,122.04 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 307,685,871.48 | 67,144,950.08 | 570,543,303.5 | 449,638,000 |
| 筹资活动现金流出小计 | 498,009,407.14 | 109,015,879.15 | 592,110,658.61 | 442,364,838.24 |
| 筹资活动产生的现金流量净额 | -190,323,535.66 | -41,870,929.07 | -21,567,355.11 | 7,273,161.76 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -80,380,218.98 | -189,082,824 | -85,425,654.03 | -209,154,325.11 |
| 期末现金及现金等价物余额 | 309,037,141.33 | 200,334,536.31 | 389,417,360.31 | 265,690,689.23 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -80,380,218.98 | - | -85,425,654.03 | - |